New treatments help those with mild, moderate and severe eczema
Crisaborole and dupilumab approved for atopic dermatitis…
List view / Grid view
Crisaborole and dupilumab approved for atopic dermatitis…
The Anacor acquisition adds crisaborole, a differentiated non-steroidal topical PDE4 inhibitor with anti-inflammatory properties, to Pfizer's pipeline...